The shift to digital approval for clinical trials is in the future for India. According to the Economic Times, unique ID numbers will be assigned where a running track of updates, personal details for the patients, a log of adverse effects and more will be recorded and regularly updated. One major concern of a project like this is the safety of the patient information - which would now be available in a digital format.
India, along with Vietnam, Malaysia and Nigeria will be joining us at Partnerships in Clinical Trials Asia to review regulatory standards across countries during the panel Global Regulatory Updates for Clinical Trials. In this panel, countries will review regulatory updates and developments, ethical and cultural diversity issues, changing regulations and localizing protocols for the different markets. Find out more about this sessions and the rest of the program by downloading the brochure. If you'd like to join us this September 16-18 in Shanghai, as a reader of this blog, when you register to join us and mention code XP1975BLOG, you can save 15% off the standard rate.
The Partnerships in Clinical Trials Blog focuses on optimization intelligence, regulatory trends and globalization strategies for both sponsors and CROs. It is supported by a number of industry events.
Would you like to guest blog on our site? Or send us feedback? Send an email to email@example.com.